Dallah Health profit drops 45% to SAR 84.5M in Q1 2026

Dallah Healthcare Co. (Dallah Health) posted a net profit drop of 45% to SAR 84.5 million from SAR 155.6 million in Q1 2025.

The company attributed the profit decline to a non-recurring event in Q1 2025, when the company entered into a real estate fund with a 33.33% stake through an in-kind contribution of land, resulting in gains of SAR 51 million during Q1 2025.

Financing costs and operating expenses increased by SAR 64 million during Q1 2026, mainly due to the consolidation of the results of Dallah Al Khobar Hospital and Dallah Al Ahsa Hospital into the group’s consolidated statements during the quarter.

Adjusted net profit before financing costs, amortization, depreciation, and Zakat — excluding the impact of the non-recurring gain — rose 7% in Q1 2026 to SAR 194 million, compared to SAR 181 million in Q1 2025.

However, revenue increased by 21.7%, supported by higher patient visit volumes across the group, particularly at Dallah Al Khobar Hospital and Dallah Al Ahsa Hospital, reflecting the positive impact of the acquisition on revenue growth during the quarter.

Total visits across the group rose 27.5% to 936,000 from 734,000 in the corresponding quarter last year.

Dallah Health’s net earnings fell 27.5% from SAR 116.55 million in Q4 2025, mainly due to lower revenues.

Shareholders’ equity, excluding minority interest, reached SAR 4.10 billion as of March 31, 2026, up from SAR 4.06 billion a year earlier.

Attached document:

View More Financial Results